Balanced news tone
News Sentiment
MGTX sentiment intelligence
MeiraGTx Holdings PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-7.1% over one week, +9.9% over four weeks, trend active, and materially above fair value.
Form 4 MeiraGTx Holdings PLC For: 21 July By Investing.com
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Form 4 MeiraGTx Holdings PLC For: 21 July By Investing.com
This article from Investing.com reports on a Form 4 filing for MeiraGTx Holdings PLC, dated July 21. Form 4s disclose changes in beneficial ownership of a company's securities by its directors, officers, and principal stockholders. The specific details of the filing are not provi
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 22 Jul 2026 02:41
- Source
- Investing.com Nigeria
MeiraGTx CFO & COO Giroux sells $700,560 in shares By Investing.com
Richard Giroux, CFO and COO of MeiraGTx Holdings plc (NASDAQ:MGTX), sold 56,000 ordinary shares worth $700,560 on July 21, 2026, under a pre-arranged trading plan. This sale occurred while the company's shares have seen significant gains year-to-date and are trading near its mark
- Tone
- Negative 35/100
- Event
- Market update
- Published
- 22 Jul 2026 02:41
- Source
- Investing.com Nigeria
Form 144 MEIRAGTX HOLDINGS PLC For: 21 July By Investing.com
This article reports on a Form 144 filing by MEIRAGTX HOLDINGS PLC for July 21st. It briefly notes the company's stock symbol MGTX and its current performance (+2.54%). The content primarily serves as a placeholder for the filing information, surrounded by general financial marke
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jul 2026 01:41
- Source
- Investing.com Canada
MeiraGTx Holdings (NASDAQ: MGTX) CFO sells 56,000 shares in plan trade
MeiraGTx Holdings' CFO & COO, Richard Giroux, sold 56,000 Ordinary Shares on July 21, 2026, at a weighted average price of $12.51 per share, following a Rule 10b5-1 trading plan adopted in November 2025. After these transactions, Giroux directly holds 908,530 Ordinary Shares, wit
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 22 Jul 2026 01:41
- Source
- Stock Titan
A Quick Look at Today's Ratings for MeiraGTx Holdings(MGTX.US), With a Forecast Between $19 to $30
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 19 Jul 2026 19:19
- Source
- Moomoo
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2026 13:55
- Source
- Market source
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 19:39
- Source
- Motley Fool
MeiraGTx Holdings (MGTX) Secures Oberland Funding, Is The Stock Fully Valued?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- simplywall.st
Latham Advises MeiraGTx on Strategic Investment by Oberland Capital
Latham & Watkins LLP advised MeiraGTx Holdings plc on a strategic investment of up to US$400 million from Oberland Capital Management LLC. The investment includes up to US$375 million in non-dilutive capital for capped royalty payments and up to US$25 million in equity. A cross-b
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 09 Jul 2026 00:39
- Source
- Latham & Watkins LLP
MeiraGTx Holdings (MGTX) Is Up 8.5% After Securing US$425M In New Funding Pathways – Has The Bull Case Changed?
MeiraGTx Holdings recently secured significant funding, including a private placement of $25 million with an option for an additional $15 million, and up to $400 million from Oberland Capital. This capital infusion substantially enhances the company's financial resources to advan
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 18:10
- Source
- Simply Wall Street
RBC Capital Adjusts MeiraGTx Price Target to $26 From $25, Maintains Outperform Speculative Risk Rating
RBC Capital has increased its price target for MeiraGTx Holdings plc (MGTX) to $26 from $25, while maintaining an "Outperform Speculative Risk" rating. This adjustment follows news that MeiraGTx’s royalty deal is strengthening funding for its commercial launch. MeiraGTx is a clin
- Tone
- Positive 70/100
- Event
- Analyst action
- Published
- 08 Jul 2026 11:11
- Source
- marketscreener.com
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jul 2026 07:00
- Source
- Market source
Form 144 MeiraGTx Holdings plc For: 7 July By Investing.com
This article announces the filing of Form 144 for MeiraGTx Holdings plc on July 7th. It is a brief administrative notice from Investing.com, providing basic information about the filing and the company's stock symbol (MGTX).
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 06:10
- Source
- Investing.com Nigeria
Insider Sell: Stuart Naylor Sells 27,659 Shares of MeiraGTx Holdings PLC (MGTX)
Stuart Naylor, Chief Scientific Officer at MeiraGTx Holdings PLC, sold 27,659 shares of the company on July 7, 2026, reducing his total holdings to 640,846 shares. This transaction follows a pattern of 9 insider sells and 0 buys at MeiraGTx Holdings PLC over the past year. The st
- Tone
- Negative 37/100
- Event
- Market update
- Published
- 08 Jul 2026 05:15
- Source
- GuruFocus
Form 4 MeiraGTx Holdings PLC For: 7 July By Investing.com
This article reports on the filing of Form 4 for MeiraGTx Holdings PLC on July 7, 2026. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of a company's securities by corporate ins
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 02:09
- Source
- Investing.com Nigeria
Meiragtx chief scientific officer Naylor sells $409,470 in shares
MeiraGTx Chief Scientific Officer Stuart Naylor sold ordinary shares worth $409,470 on July 7, 2026, through a Rule 10b5-1 trading plan. The sales occurred after MGTX stock surged 101% in six months, with shares trading near a 52-week high, although InvestingPro analysis suggests
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 01:09
- Source
- Investing.com
MeiraGTx (MGTX) chief scientist sells 27,659 shares in pre-set 10b5-1 trades
MeiraGTx Holdings plc's chief scientific officer for ophthalmology, Stuart Naylor, sold 27,659 ordinary shares on July 7, 2026, through open-market transactions. The sales occurred at weighted average prices ranging from $13.36 to $15.33 per share across multiple trades. These tr
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 08 Jul 2026 01:09
- Source
- Stock Titan
Enterprise value to EBIT forward of MeiraGTx Holdings plc – NASDAQ:MGTX
This article provides a financial metric—enterprise value to EBIT forward—for MeiraGTx Holdings plc, traded on NASDAQ under the symbol MGTX. It appears to be a stub or a section of a larger financial data service from TradingView, offering a snapshot of this specific valuation ra
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 20:11
- Source
- TradingView
MeiraGTx secures up to $400M from Oberland Capital
MeiraGTx Holdings plc has secured up to $400 million in investment from Oberland Capital Management LLC. This non-dilutive financing includes capped royalty payments on several products and an equity investment, bolstering the company's liquidity. The deal is tied to future data
- Tone
- Positive 74/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 18:10
- Source
- Investing.com
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec
MeiraGTx, a clinical-stage genetic medicines company, has secured a strategic investment of up to $400 million from Oberland Capital Management LLC. This funding, comprising up to $375 million in non-dilutive capital and up to $25 million in equity, will support the development a
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 07 Jul 2026 13:42
- Source
- Investing News Network
Meiragtx Holdings Plc shares rose 3.5% in pre-market trading.
Meiragtx Holdings Plc experienced a 3.5% rise in pre-market trading following a strategic investment of up to $400 million from Oberland Capital. This capital infusion is expected to bolster the company's R&D capabilities and operational funding, leading to increased investor con
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 07 Jul 2026 13:42
- Source
- Bitget
MGTX (NASDAQ): Proposed resale notice for 27,659 ordinary shares
MGTX (MeiraGTx Holdings plc) has submitted a Form 144 notice indicating a proposed sale of 27,659 ordinary shares with a gross value of $368,694.47 through Fidelity Brokerage Services LLC, referenced to July 7, 2026, on NASDAQ. The filing also notes a previous sale by Stuart Nayl
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 13:42
- Source
- Stock Titan
MeiraGTx (Nasdaq: MGTX) lands $400M Oberland royalty and equity deal
MeiraGTx Holdings plc secured a strategic financing deal totaling up to $400 million with Oberland Capital. This includes up to $375 million in non-dilutive royalty notes tied to the net sales of three late-stage gene therapies (AAV-AIPL1, AAV2-hAQP1, and bota-vec) and an equity
- Tone
- Positive 85/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 11:42
- Source
- Stock Titan
MeiraGTx Secures Up To $375 Million Royalty Financing, Adds $10 Million Equity, Retires Perceptive Debt
MeiraGTx has successfully completed a significant financing and refinancing package. The company secured up to $375 million in royalty-backed funding from Oberland Capital, raised $10 million through a private share placement, and retired its Perceptive Credit notes without penal
- Tone
- Positive 74/100
- Event
- Balance sheet
- Published
- 07 Jul 2026 11:42
- Source
- TradingView
MeiraGTx wins $400M investment from Oberland Capital
MeiraGTx Holdings plc secured up to $400 million in funding from Oberland Capital Management LLC. This investment will support the development of MeiraGTx's gene therapy candidates. Following the announcement, the company's shares rose about 7% in premarket trading.
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 07 Jul 2026 11:42
- Source
- Seeking Alpha
MeiraGTx Holdings outlines its gene therapy ambitions as a mid-cap biotech
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Ad-hoc-news.de
MeiraGTx secures up to $400M to fund gene therapy launches
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Stock Titan
MGTX - MeiraGTx Holdings plc Options
This article provides a detailed financial overview of MeiraGTx Holdings plc (MGTX), including its market capitalization, enterprise value, income, sales, and various financial ratios. It also lists key performance indicators such as EPS, sales growth, insider and institutional o
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jul 2026 04:40
- Source
- Finviz